***Background.*** Botswana has an HIV prevalence of 19% among those aged 18 months-64 years. Community-acquired pneumonia (CAP) is a leading cause for admission to our referral hospital in Gaborone. We collaborated with the Ministry of Health and the University of Botswana to implement an inpatient treatment guideline for CAP. We hypothesized that implementation of a guideline for CAP would be associated with improved clinical outcomes.

***Methods.*** We performed a prospective observational study among adults admitted with CAP to evaluate guideline use. Inclusion criteria: age \>18, diagnosis of CAP and meeting the case definition of CAP. Data collection captured HIV status, CD4 count, antimicrobials used, chest radiograph findings, microbiologic diagnoses and outcomes. We assessed mortality by contacting study subjects or a designated contact at 30 days following discharge. Guideline fidelity was assessed by a 5 point score assigning 1 point for each of the following: appropriate antibiotic use (1 point for Beta-lactam, 1 point for doxycycline or erythromycin), blood cultures obtained, smear for acid fast bacilli obtained on HIV-infected patients or subjects with cough \> one week, chest radiograph reviewed. Analysis compared proportions using Chi-square test at the 95% confidence level, and rank sum test for continuous measures.

***Results.*** Patient demographics are included in the table.

  Characteristic                  HIV-n                     HIV+        Total        p value               
  ------------------------------ ------- ---------------- -------- ---------------- --------- ------------ --------------
  Total                            74          17%          365          83%           441        100%     
  **Age**                          74     **61** (40-67)    365     **38** (32-45)     441     39 (32-49)  **\<0.0001**
  **Diabetes**                    12/74      **16%**       9/364        **2%**       21/440        5%      **0.0001**
  Chronic renal failure           4/74          5%         9/365          2%         13/441        3%      0.17
  **Chronic heart disease**       9/74       **12%**       2/365       **0.5%**      11/441        2%      **0.0001**
  **COPD**                        8/74       **11%**       5/364        **1%**       13/440        3%      **0.0001**
  Underlying malignancy           1/74          1%         1/365         0.3%         2/440       0.5%     0.22
  Antibiotics in past 3 months    2/73          3%         11/364         3%         13/439        3%      0.90

Overall 30-day mortality was 24%. Mortality among HIV-infected subjects was 24% and among HIV-negative subjects was 23%, p = 0.8. Mean guideline adherence score for those who were alive at 30 days was 2.45 (95% CI 2.34-2.56) compared to those who died, 2.09 (95% CI 1.87-2.32), p = 0.006.

***Conclusion.*** In this setting, higher adherence to a guideline for community-acquired pneumonia is associated with a reduction in mortality.
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